Wentland M P, Perni R B, Dorff P H, Rake J B
Department of Medicinal Chemistry, Sterling-Winthrop Research Institute, Rensselaer, New York 12144.
J Med Chem. 1988 Sep;31(9):1694-7. doi: 10.1021/jm00117a005.
A novel conformationally restricted 1-cyclopropylquinolone (1) that incorporates structural features of both ofloxacin and ciprofloxacin has been prepared. Compound 1 was found to be a DNA gyrase inhibitor having potency similar to ofloxacin but less than ciprofloxacin. The cellular inhibitory and in vivo antibacterial potencies of 1 were found to be less than those of the two reference agents.